Skip to Main Content
Skip Nav Destination

Issues

Acta Haematologica 2022, Vol. 145, No. 5

Original Paper

Subject Area: Hematology , Oncology
Acta Haematol (2022) 145 (5): 465–475. https://doi.org/10.1159/000521912
Subject Area: Hematology , Oncology
Acta Haematol (2022) 145 (5): 476–483. https://doi.org/10.1159/000524094
Subject Area: Hematology , Oncology
Acta Haematol (2022) 145 (5): 484–498. https://doi.org/10.1159/000524158
Subject Area: Hematology , Oncology
Acta Haematol (2022) 145 (5): 499–504. https://doi.org/10.1159/000524535
Subject Area: Hematology , Oncology
Acta Haematol (2022) 145 (5): 505–516. https://doi.org/10.1159/000524569
Subject Area: Hematology , Oncology
Acta Haematol (2022) 145 (5): 517–528. https://doi.org/10.1159/000525055
Subject Area: Hematology , Oncology
Acta Haematol (2022) 145 (5): 529–536. https://doi.org/10.1159/000525566

Case Report

Subject Area: Hematology , Oncology
Acta Haematol (2022) 145 (5): 537–541. https://doi.org/10.1159/000525576

Brief Report

Subject Area: Hematology , Oncology
Acta Haematol (2022) 145 (5): 542–552. https://doi.org/10.1159/000523873

Case Report

Subject Area: Hematology , Oncology
Acta Haematol (2022) 145 (5): 553–559. https://doi.org/10.1159/000525056
Subject Area: Hematology , Oncology
Acta Haematol (2022) 145 (5): 560–565. https://doi.org/10.1159/000524275
Subject Area: Hematology , Oncology
Acta Haematol (2022) 145 (5): 566–570. https://doi.org/10.1159/000524878

Pharma News

Subject Area: Hematology , Oncology
Acta Haematol (2022) 145 (5): 572–574. https://doi.org/10.1159/000526949
Close Modal

or Create an Account

Close Modal
Close Modal